rat anti gfap antibody  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs rat anti gfap antibody
    Rat Anti Gfap Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti gfap antibody/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rat anti gfap antibody - by Bioz Stars, 2023-01
    94/100 stars

    Images

    rat anti gfap antibody  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs rat anti gfap antibody
    Rat Anti Gfap Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti gfap antibody/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rat anti gfap antibody - by Bioz Stars, 2023-01
    94/100 stars

    Images

    mouse anti rat gfap antibody  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Alomone Labs mouse anti rat gfap antibody
    Mouse Anti Rat Gfap Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti rat gfap antibody/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mouse anti rat gfap antibody - by Bioz Stars, 2023-01
    86/100 stars

    Images

    anti rabbit  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs anti rabbit
    Anti Rabbit, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rabbit/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti rabbit - by Bioz Stars, 2023-01
    94/100 stars

    Images

    gfap antibodies  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Alomone Labs gfap antibodies
    <t>TRPV4</t> activation enhances the expression of <t>GFAP.</t> A Immunofluorescence images show GFAP protein expression profiles in rat retinal vertical slices acquired from sham-operated retinas (saline-injected; control) ( A1 ), 1 µM GSK101-injected retinas ( A2 ), and 10 µM GSK101-injected retinas ( A3 ). Retinas that received no GFAP antibody served as negative controls ( A4 ). Double immunofluorescence staining showing GFAP expression when the GFAP antibody was pre-adsorbed with its blocking peptide (BP) ( A5 ). Scale bar: 20 µm. B Representative immunoblots showing changes in GFAP protein levels in control and 10 µM GSK101-injected retinas. C Bar chart summarizing mean expression levels of GFAP under different conditions. n = 6. * p < 0.05 vs control
    Gfap Antibodies, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gfap antibodies/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    gfap antibodies - by Bioz Stars, 2023-01
    86/100 stars

    Images

    1) Product Images from "TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway"

    Article Title: TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway

    Journal: Journal of Neuroinflammation

    doi: 10.1186/s12974-021-02315-8

    TRPV4 activation enhances the expression of GFAP. A Immunofluorescence images show GFAP protein expression profiles in rat retinal vertical slices acquired from sham-operated retinas (saline-injected; control) ( A1 ), 1 µM GSK101-injected retinas ( A2 ), and 10 µM GSK101-injected retinas ( A3 ). Retinas that received no GFAP antibody served as negative controls ( A4 ). Double immunofluorescence staining showing GFAP expression when the GFAP antibody was pre-adsorbed with its blocking peptide (BP) ( A5 ). Scale bar: 20 µm. B Representative immunoblots showing changes in GFAP protein levels in control and 10 µM GSK101-injected retinas. C Bar chart summarizing mean expression levels of GFAP under different conditions. n = 6. * p < 0.05 vs control
    Figure Legend Snippet: TRPV4 activation enhances the expression of GFAP. A Immunofluorescence images show GFAP protein expression profiles in rat retinal vertical slices acquired from sham-operated retinas (saline-injected; control) ( A1 ), 1 µM GSK101-injected retinas ( A2 ), and 10 µM GSK101-injected retinas ( A3 ). Retinas that received no GFAP antibody served as negative controls ( A4 ). Double immunofluorescence staining showing GFAP expression when the GFAP antibody was pre-adsorbed with its blocking peptide (BP) ( A5 ). Scale bar: 20 µm. B Representative immunoblots showing changes in GFAP protein levels in control and 10 µM GSK101-injected retinas. C Bar chart summarizing mean expression levels of GFAP under different conditions. n = 6. * p < 0.05 vs control

    Techniques Used: Activation Assay, Expressing, Immunofluorescence, Injection, Double Immunofluorescence Staining, Blocking Assay, Western Blot

    TRPV4 activation enhances TNF-α production in cultured Müller cells. A Morphology of cultured Müller cells. Scale bar: 50 µm. B GSK101 treatment enhanced GFAP protein levels in cultured Müller cells. n = 4. ** p < 0.01 and *** p < 0.001. C Cumulative changes in GFAP protein levels in control and GSK101 treatment groups. D – F Cumulative changes in mRNA levels of TNF-α ( D ), IL-1β ( E ), and IL-6 ( F ) in Müller cell extracts obtained after saline treatment (control) or GSK101 treatment for 24 h. Relative abundances of mRNA were quantified using the 2 −ΔΔct calculation method and are expressed as fold changes. n = 3 for all groups. * p < 0.05 vs control. G , GSK101 treatment led to enhancement of TNF-α protein level. H Cumulative changes in TNF-α protein levels in control and GSK101 treatment groups. n = 6. * p < 0.05 and *** p < 0.001
    Figure Legend Snippet: TRPV4 activation enhances TNF-α production in cultured Müller cells. A Morphology of cultured Müller cells. Scale bar: 50 µm. B GSK101 treatment enhanced GFAP protein levels in cultured Müller cells. n = 4. ** p < 0.01 and *** p < 0.001. C Cumulative changes in GFAP protein levels in control and GSK101 treatment groups. D – F Cumulative changes in mRNA levels of TNF-α ( D ), IL-1β ( E ), and IL-6 ( F ) in Müller cell extracts obtained after saline treatment (control) or GSK101 treatment for 24 h. Relative abundances of mRNA were quantified using the 2 −ΔΔct calculation method and are expressed as fold changes. n = 3 for all groups. * p < 0.05 vs control. G , GSK101 treatment led to enhancement of TNF-α protein level. H Cumulative changes in TNF-α protein levels in control and GSK101 treatment groups. n = 6. * p < 0.05 and *** p < 0.001

    Techniques Used: Activation Assay, Cell Culture

    anti gfap antibody  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Alomone Labs anti gfap antibody
    Co-localization of TRPA1 and SFKs, and effects of pYEEI, the SFKs activator, on the anti-TRPA1 antibody-reduced cortical susceptibility to CSD in the mouse brain slice. ( A , B ) Representative images of expression of SFKs in neurons and astrocytes of mouse cerebral cortices. ( C ) Representative images of co-localization of TRPA1 and SFKs in mouse cerebral cortices. Staining with DAPI indicated nucleus as shown in blue; staining with the anti-TRPA1 antibody was shown in red; staining with the anti-NeuN antibody indicated neurons and staining with <t>the</t> <t>anti-GFAP</t> antibody indicated astrocytes as shown in green. Double immune-labeling showed expression of SFKs in neurons and astrocytes of mouse cerebral cortices or co-expression of TRPA1 and SFKs in mouse cerebral cortices (white arrows, n = 3 per group). ( D ) Representative images of the coronal slice of mouse brain before (upper) and after (lower) CSD induced by ejection of 260 mM KCl in the cerebral cortical region. The same area of interest (AOI) along CSD wave front (pointed by the short arrow) was selected and used for all images. ( E ) The averaged gray level within the AOI was plotted against time to generate the CSD curve. ( F , G ) Effects of 0.015 µM anti-TRPA1 antibody (Anti-TRPA1) ( n = 7), 0.015 µM anti-TRPA1 antibody + 0.1 µM pYEEI ( n = 7), or 0.015 µM anti-TRPA1 antibody + 0.1 µM YEEI ( n = 8) on CSD latency (seconds, s) and CSD propagation rate (mm/minute, mm/min) in mouse brain slices. Group data were presented as mean ± SEM. Two-tailed unpaired t -test was used for comparison between pYEEI and YEEI group in the presence of anti-TRPA1 antibody. Significance differences were shown as * p < 0.05, ** p < 0.01.
    Anti Gfap Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti gfap antibody/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti gfap antibody - by Bioz Stars, 2023-01
    86/100 stars

    Images

    1) Product Images from "TRPA1-Mediated Src Family Kinases Activity Facilitates Cortical Spreading Depression Susceptibility and Trigeminovascular System Sensitization"

    Article Title: TRPA1-Mediated Src Family Kinases Activity Facilitates Cortical Spreading Depression Susceptibility and Trigeminovascular System Sensitization

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms222212273

    Co-localization of TRPA1 and SFKs, and effects of pYEEI, the SFKs activator, on the anti-TRPA1 antibody-reduced cortical susceptibility to CSD in the mouse brain slice. ( A , B ) Representative images of expression of SFKs in neurons and astrocytes of mouse cerebral cortices. ( C ) Representative images of co-localization of TRPA1 and SFKs in mouse cerebral cortices. Staining with DAPI indicated nucleus as shown in blue; staining with the anti-TRPA1 antibody was shown in red; staining with the anti-NeuN antibody indicated neurons and staining with the anti-GFAP antibody indicated astrocytes as shown in green. Double immune-labeling showed expression of SFKs in neurons and astrocytes of mouse cerebral cortices or co-expression of TRPA1 and SFKs in mouse cerebral cortices (white arrows, n = 3 per group). ( D ) Representative images of the coronal slice of mouse brain before (upper) and after (lower) CSD induced by ejection of 260 mM KCl in the cerebral cortical region. The same area of interest (AOI) along CSD wave front (pointed by the short arrow) was selected and used for all images. ( E ) The averaged gray level within the AOI was plotted against time to generate the CSD curve. ( F , G ) Effects of 0.015 µM anti-TRPA1 antibody (Anti-TRPA1) ( n = 7), 0.015 µM anti-TRPA1 antibody + 0.1 µM pYEEI ( n = 7), or 0.015 µM anti-TRPA1 antibody + 0.1 µM YEEI ( n = 8) on CSD latency (seconds, s) and CSD propagation rate (mm/minute, mm/min) in mouse brain slices. Group data were presented as mean ± SEM. Two-tailed unpaired t -test was used for comparison between pYEEI and YEEI group in the presence of anti-TRPA1 antibody. Significance differences were shown as * p < 0.05, ** p < 0.01.
    Figure Legend Snippet: Co-localization of TRPA1 and SFKs, and effects of pYEEI, the SFKs activator, on the anti-TRPA1 antibody-reduced cortical susceptibility to CSD in the mouse brain slice. ( A , B ) Representative images of expression of SFKs in neurons and astrocytes of mouse cerebral cortices. ( C ) Representative images of co-localization of TRPA1 and SFKs in mouse cerebral cortices. Staining with DAPI indicated nucleus as shown in blue; staining with the anti-TRPA1 antibody was shown in red; staining with the anti-NeuN antibody indicated neurons and staining with the anti-GFAP antibody indicated astrocytes as shown in green. Double immune-labeling showed expression of SFKs in neurons and astrocytes of mouse cerebral cortices or co-expression of TRPA1 and SFKs in mouse cerebral cortices (white arrows, n = 3 per group). ( D ) Representative images of the coronal slice of mouse brain before (upper) and after (lower) CSD induced by ejection of 260 mM KCl in the cerebral cortical region. The same area of interest (AOI) along CSD wave front (pointed by the short arrow) was selected and used for all images. ( E ) The averaged gray level within the AOI was plotted against time to generate the CSD curve. ( F , G ) Effects of 0.015 µM anti-TRPA1 antibody (Anti-TRPA1) ( n = 7), 0.015 µM anti-TRPA1 antibody + 0.1 µM pYEEI ( n = 7), or 0.015 µM anti-TRPA1 antibody + 0.1 µM YEEI ( n = 8) on CSD latency (seconds, s) and CSD propagation rate (mm/minute, mm/min) in mouse brain slices. Group data were presented as mean ± SEM. Two-tailed unpaired t -test was used for comparison between pYEEI and YEEI group in the presence of anti-TRPA1 antibody. Significance differences were shown as * p < 0.05, ** p < 0.01.

    Techniques Used: Slice Preparation, Expressing, Staining, Labeling, Two Tailed Test

    glial fibrillary acidic protein gfap  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs glial fibrillary acidic protein gfap
    (a) AQP-4 immunostaining of retina in control (a), 1h (b) and 18h (c) animals. <t>(d-f)</t> <t>Kir4.1</t> immunostaining. (g-i) <t>GFAP</t> immunostaining (green) and DAPI nuclei labeling (blue). (j-l) TUNEL (red, arrows) and DAPI (blue). (m, n) Bar graph of quantification of AQP-4 (m) and Kir4.1 (n) expression levels in the retina and correlation with retinal thickness. (o) Bar graph of quantification of GFAP + processes across the IPL and correlation with retinal thickness. (p) Bar graph of quantification of the number of TUNEL + cells in each retina layer per retinal section. GCL: ganglion cell layer; INL: inner nuclear layer; IPL: inner plexiform layer; OPL: outer plexiform layer, ONL: outer nuclear layer.
    Glial Fibrillary Acidic Protein Gfap, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glial fibrillary acidic protein gfap/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glial fibrillary acidic protein gfap - by Bioz Stars, 2023-01
    94/100 stars

    Images

    1) Product Images from "Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes"

    Article Title: Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0246681

    (a) AQP-4 immunostaining of retina in control (a), 1h (b) and 18h (c) animals. (d-f) Kir4.1 immunostaining. (g-i) GFAP immunostaining (green) and DAPI nuclei labeling (blue). (j-l) TUNEL (red, arrows) and DAPI (blue). (m, n) Bar graph of quantification of AQP-4 (m) and Kir4.1 (n) expression levels in the retina and correlation with retinal thickness. (o) Bar graph of quantification of GFAP + processes across the IPL and correlation with retinal thickness. (p) Bar graph of quantification of the number of TUNEL + cells in each retina layer per retinal section. GCL: ganglion cell layer; INL: inner nuclear layer; IPL: inner plexiform layer; OPL: outer plexiform layer, ONL: outer nuclear layer.
    Figure Legend Snippet: (a) AQP-4 immunostaining of retina in control (a), 1h (b) and 18h (c) animals. (d-f) Kir4.1 immunostaining. (g-i) GFAP immunostaining (green) and DAPI nuclei labeling (blue). (j-l) TUNEL (red, arrows) and DAPI (blue). (m, n) Bar graph of quantification of AQP-4 (m) and Kir4.1 (n) expression levels in the retina and correlation with retinal thickness. (o) Bar graph of quantification of GFAP + processes across the IPL and correlation with retinal thickness. (p) Bar graph of quantification of the number of TUNEL + cells in each retina layer per retinal section. GCL: ganglion cell layer; INL: inner nuclear layer; IPL: inner plexiform layer; OPL: outer plexiform layer, ONL: outer nuclear layer.

    Techniques Used: Immunostaining, Labeling, TUNEL Assay, Expressing

    glial fibrillary acidic protein gfap rabbit dako z0334  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs glial fibrillary acidic protein gfap rabbit dako z0334
    List of primary and secondary antibodies used in the study.
    Glial Fibrillary Acidic Protein Gfap Rabbit Dako Z0334, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glial fibrillary acidic protein gfap rabbit dako z0334/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glial fibrillary acidic protein gfap rabbit dako z0334 - by Bioz Stars, 2023-01
    94/100 stars

    Images

    1) Product Images from "TAF1 -gene editing alters the morphology and function of the cerebellum"

    Article Title: TAF1 -gene editing alters the morphology and function of the cerebellum

    Journal: Neurobiology of disease

    doi: 10.1016/j.nbd.2019.104539

    List of primary and secondary antibodies used in the study.
    Figure Legend Snippet: List of primary and secondary antibodies used in the study.

    Techniques Used: Binding Assay

    (A) Expression of calbindin was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of Calbindin positive Purkinje cells in TAF1-edited animals compared to control animals. B) Expression of GFAP (astrocytes marker) was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of GFAP positive cells in TAF1-edited animals compared to control animals. (C) Expression of Iba1 (microglia marker) was increased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also increase in the number of Iba1 positive cells in TAF1-edited animals compared to control animals. (D) Summary of the number of Purkinje cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 12 fields per animal, 4 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). (E) and (F) Summary of the number of GFAP positive cells and Iba1 positive cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 9 fields per animal, 3 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). The experiments were conducted in an investigator blinded manner.
    Figure Legend Snippet: (A) Expression of calbindin was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of Calbindin positive Purkinje cells in TAF1-edited animals compared to control animals. B) Expression of GFAP (astrocytes marker) was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of GFAP positive cells in TAF1-edited animals compared to control animals. (C) Expression of Iba1 (microglia marker) was increased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also increase in the number of Iba1 positive cells in TAF1-edited animals compared to control animals. (D) Summary of the number of Purkinje cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 12 fields per animal, 4 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). (E) and (F) Summary of the number of GFAP positive cells and Iba1 positive cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 9 fields per animal, 3 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). The experiments were conducted in an investigator blinded manner.

    Techniques Used: Expressing, CRISPR, Marker

    glial fibrillary acidic protein gfap rabbit dako z0334  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs glial fibrillary acidic protein gfap rabbit dako z0334
    List of primary and secondary antibodies used in the study.
    Glial Fibrillary Acidic Protein Gfap Rabbit Dako Z0334, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glial fibrillary acidic protein gfap rabbit dako z0334/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glial fibrillary acidic protein gfap rabbit dako z0334 - by Bioz Stars, 2023-01
    94/100 stars

    Images

    1) Product Images from "TAF1 -gene editing alters the morphology and function of the cerebellum"

    Article Title: TAF1 -gene editing alters the morphology and function of the cerebellum

    Journal: Neurobiology of disease

    doi: 10.1016/j.nbd.2019.104539

    List of primary and secondary antibodies used in the study.
    Figure Legend Snippet: List of primary and secondary antibodies used in the study.

    Techniques Used: Binding Assay

    (A) Expression of calbindin was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of Calbindin positive Purkinje cells in TAF1-edited animals compared to control animals. B) Expression of GFAP (astrocytes marker) was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of GFAP positive cells in TAF1-edited animals compared to control animals. (C) Expression of Iba1 (microglia marker) was increased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also increase in the number of Iba1 positive cells in TAF1-edited animals compared to control animals. (D) Summary of the number of Purkinje cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 12 fields per animal, 4 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). (E) and (F) Summary of the number of GFAP positive cells and Iba1 positive cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 9 fields per animal, 3 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). The experiments were conducted in an investigator blinded manner.
    Figure Legend Snippet: (A) Expression of calbindin was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of Calbindin positive Purkinje cells in TAF1-edited animals compared to control animals. B) Expression of GFAP (astrocytes marker) was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of GFAP positive cells in TAF1-edited animals compared to control animals. (C) Expression of Iba1 (microglia marker) was increased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also increase in the number of Iba1 positive cells in TAF1-edited animals compared to control animals. (D) Summary of the number of Purkinje cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 12 fields per animal, 4 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). (E) and (F) Summary of the number of GFAP positive cells and Iba1 positive cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 9 fields per animal, 3 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). The experiments were conducted in an investigator blinded manner.

    Techniques Used: Expressing, CRISPR, Marker

    gfap  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs gfap
    Gfap, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gfap/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    gfap - by Bioz Stars, 2023-01
    94/100 stars

    Images

    gfap  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs gfap
    Hypertension induces brain Aβ deposition and glymphatic clearance impairment. (a–d) In vivo imaging of Aβ deposition in the cerebral cortex. Aβ deposition (FSB, green) was distinct along the vessels. (e) Enlarged VRS were observed. (f) 3D reconstruction of the vasculature in hypertension mice. The warping vessel is magnified on the right panel. (g-j) Ang-II evoked a significant increase in systolic blood pressure (SBP) and diastolic blood pressure (DBP) with no changes in heart rates (HR) and body weight (k-m). Glymphatic clearance impairment was evident in hypertension models. (n-o) Arterial diameters remained unchanged in hypertension models while vascular pulsatility was severely reduced (n=8-9 vessels per group) (s) . (q) Representative images of <t>GFAP</t> expression <t>and</t> <t>AQP4</t> polarization in the cortex. No distinctive changes in AQP4 polarization (t) and GFAP expression (u) were observed in the hypertension model. (p, upper panel) Representative images of smooth muscle actin (SMA) and collagen expression in the cortex. No significant changes in SMA expression (r) and greater deposition of collagen (r) in vascular walls were observed in hypertension models. (p, lower panel) Immunology of Aβ 1–40 and Aβ 1–42 in hypertension model mice. Significant deposition of Aβ 1–40, but not Aβ 1–42, in vessels was observed. (p, lower panel) Co-labeling of collagen and Aβ 1–40 in hypertension. Aβ 1–40 co-localized with collagen (n=5-6 mice per group).
    Gfap, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gfap/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    gfap - by Bioz Stars, 2023-01
    94/100 stars

    Images

    1) Product Images from "Glutamate and γ-aminobutyric acid differentially modulate glymphatic clearance of amyloid β through pulsation- and aquaporin-4 dependent mechanisms"

    Article Title: Glutamate and γ-aminobutyric acid differentially modulate glymphatic clearance of amyloid β through pulsation- and aquaporin-4 dependent mechanisms

    Journal: bioRxiv

    doi: 10.1101/2020.01.31.928481

    Hypertension induces brain Aβ deposition and glymphatic clearance impairment. (a–d) In vivo imaging of Aβ deposition in the cerebral cortex. Aβ deposition (FSB, green) was distinct along the vessels. (e) Enlarged VRS were observed. (f) 3D reconstruction of the vasculature in hypertension mice. The warping vessel is magnified on the right panel. (g-j) Ang-II evoked a significant increase in systolic blood pressure (SBP) and diastolic blood pressure (DBP) with no changes in heart rates (HR) and body weight (k-m). Glymphatic clearance impairment was evident in hypertension models. (n-o) Arterial diameters remained unchanged in hypertension models while vascular pulsatility was severely reduced (n=8-9 vessels per group) (s) . (q) Representative images of GFAP expression and AQP4 polarization in the cortex. No distinctive changes in AQP4 polarization (t) and GFAP expression (u) were observed in the hypertension model. (p, upper panel) Representative images of smooth muscle actin (SMA) and collagen expression in the cortex. No significant changes in SMA expression (r) and greater deposition of collagen (r) in vascular walls were observed in hypertension models. (p, lower panel) Immunology of Aβ 1–40 and Aβ 1–42 in hypertension model mice. Significant deposition of Aβ 1–40, but not Aβ 1–42, in vessels was observed. (p, lower panel) Co-labeling of collagen and Aβ 1–40 in hypertension. Aβ 1–40 co-localized with collagen (n=5-6 mice per group).
    Figure Legend Snippet: Hypertension induces brain Aβ deposition and glymphatic clearance impairment. (a–d) In vivo imaging of Aβ deposition in the cerebral cortex. Aβ deposition (FSB, green) was distinct along the vessels. (e) Enlarged VRS were observed. (f) 3D reconstruction of the vasculature in hypertension mice. The warping vessel is magnified on the right panel. (g-j) Ang-II evoked a significant increase in systolic blood pressure (SBP) and diastolic blood pressure (DBP) with no changes in heart rates (HR) and body weight (k-m). Glymphatic clearance impairment was evident in hypertension models. (n-o) Arterial diameters remained unchanged in hypertension models while vascular pulsatility was severely reduced (n=8-9 vessels per group) (s) . (q) Representative images of GFAP expression and AQP4 polarization in the cortex. No distinctive changes in AQP4 polarization (t) and GFAP expression (u) were observed in the hypertension model. (p, upper panel) Representative images of smooth muscle actin (SMA) and collagen expression in the cortex. No significant changes in SMA expression (r) and greater deposition of collagen (r) in vascular walls were observed in hypertension models. (p, lower panel) Immunology of Aβ 1–40 and Aβ 1–42 in hypertension model mice. Significant deposition of Aβ 1–40, but not Aβ 1–42, in vessels was observed. (p, lower panel) Co-labeling of collagen and Aβ 1–40 in hypertension. Aβ 1–40 co-localized with collagen (n=5-6 mice per group).

    Techniques Used: In Vivo Imaging, Expressing, Labeling

    Impairment of glymphatic clearance and deposition of Aβ plaques in APP-PS1 mice. (a) In vivo imaging of Aβ deposition in the cerebral cortex (FSB: green). Aβ deposition was evident in the parenchyma with no distinct CAA. (b) Immunology of Aβ 1–40 and Aβ 1–42 in APP-PS1. Significant numbers of Aβ 1–42-labeled amyloid plaques were observed in the parenchyma, but no marked deposition of Aβ 1–40. (c) Representative images of paravascular CSF tracer clearance at 100 μm below the cortical surface in APP-PS1 indicating severe impairment in penetration of fluorescence tracer (e) while no changes in paravascular movement was observed (d). (h-i) Expression of AQP4 and GFAP in cortex and hippocampus. Compared with WT control mice, APP-PS1 mice displayed significant decrease in AQP4 polarization and exhibited a marked increase in GFAP expression in the cortex (n=6 mice per group). No significant pulsatility changes were observed between APP-PS1 and WT control mice (f) (n=7-8 vessels per group).
    Figure Legend Snippet: Impairment of glymphatic clearance and deposition of Aβ plaques in APP-PS1 mice. (a) In vivo imaging of Aβ deposition in the cerebral cortex (FSB: green). Aβ deposition was evident in the parenchyma with no distinct CAA. (b) Immunology of Aβ 1–40 and Aβ 1–42 in APP-PS1. Significant numbers of Aβ 1–42-labeled amyloid plaques were observed in the parenchyma, but no marked deposition of Aβ 1–40. (c) Representative images of paravascular CSF tracer clearance at 100 μm below the cortical surface in APP-PS1 indicating severe impairment in penetration of fluorescence tracer (e) while no changes in paravascular movement was observed (d). (h-i) Expression of AQP4 and GFAP in cortex and hippocampus. Compared with WT control mice, APP-PS1 mice displayed significant decrease in AQP4 polarization and exhibited a marked increase in GFAP expression in the cortex (n=6 mice per group). No significant pulsatility changes were observed between APP-PS1 and WT control mice (f) (n=7-8 vessels per group).

    Techniques Used: In Vivo Imaging, Labeling, Fluorescence, Expressing

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Alomone Labs rat anti gfap antibody
    Rat Anti Gfap Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti gfap antibody/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rat anti gfap antibody - by Bioz Stars, 2023-01
    94/100 stars
      Buy from Supplier

    86
    Alomone Labs mouse anti rat gfap antibody
    Mouse Anti Rat Gfap Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti rat gfap antibody/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mouse anti rat gfap antibody - by Bioz Stars, 2023-01
    86/100 stars
      Buy from Supplier

    94
    Alomone Labs anti rabbit
    Anti Rabbit, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rabbit/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti rabbit - by Bioz Stars, 2023-01
    94/100 stars
      Buy from Supplier

    86
    Alomone Labs gfap antibodies
    <t>TRPV4</t> activation enhances the expression of <t>GFAP.</t> A Immunofluorescence images show GFAP protein expression profiles in rat retinal vertical slices acquired from sham-operated retinas (saline-injected; control) ( A1 ), 1 µM GSK101-injected retinas ( A2 ), and 10 µM GSK101-injected retinas ( A3 ). Retinas that received no GFAP antibody served as negative controls ( A4 ). Double immunofluorescence staining showing GFAP expression when the GFAP antibody was pre-adsorbed with its blocking peptide (BP) ( A5 ). Scale bar: 20 µm. B Representative immunoblots showing changes in GFAP protein levels in control and 10 µM GSK101-injected retinas. C Bar chart summarizing mean expression levels of GFAP under different conditions. n = 6. * p < 0.05 vs control
    Gfap Antibodies, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gfap antibodies/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    gfap antibodies - by Bioz Stars, 2023-01
    86/100 stars
      Buy from Supplier

    86
    Alomone Labs anti gfap antibody
    Co-localization of TRPA1 and SFKs, and effects of pYEEI, the SFKs activator, on the anti-TRPA1 antibody-reduced cortical susceptibility to CSD in the mouse brain slice. ( A , B ) Representative images of expression of SFKs in neurons and astrocytes of mouse cerebral cortices. ( C ) Representative images of co-localization of TRPA1 and SFKs in mouse cerebral cortices. Staining with DAPI indicated nucleus as shown in blue; staining with the anti-TRPA1 antibody was shown in red; staining with the anti-NeuN antibody indicated neurons and staining with <t>the</t> <t>anti-GFAP</t> antibody indicated astrocytes as shown in green. Double immune-labeling showed expression of SFKs in neurons and astrocytes of mouse cerebral cortices or co-expression of TRPA1 and SFKs in mouse cerebral cortices (white arrows, n = 3 per group). ( D ) Representative images of the coronal slice of mouse brain before (upper) and after (lower) CSD induced by ejection of 260 mM KCl in the cerebral cortical region. The same area of interest (AOI) along CSD wave front (pointed by the short arrow) was selected and used for all images. ( E ) The averaged gray level within the AOI was plotted against time to generate the CSD curve. ( F , G ) Effects of 0.015 µM anti-TRPA1 antibody (Anti-TRPA1) ( n = 7), 0.015 µM anti-TRPA1 antibody + 0.1 µM pYEEI ( n = 7), or 0.015 µM anti-TRPA1 antibody + 0.1 µM YEEI ( n = 8) on CSD latency (seconds, s) and CSD propagation rate (mm/minute, mm/min) in mouse brain slices. Group data were presented as mean ± SEM. Two-tailed unpaired t -test was used for comparison between pYEEI and YEEI group in the presence of anti-TRPA1 antibody. Significance differences were shown as * p < 0.05, ** p < 0.01.
    Anti Gfap Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti gfap antibody/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti gfap antibody - by Bioz Stars, 2023-01
    86/100 stars
      Buy from Supplier

    94
    Alomone Labs glial fibrillary acidic protein gfap
    (a) AQP-4 immunostaining of retina in control (a), 1h (b) and 18h (c) animals. <t>(d-f)</t> <t>Kir4.1</t> immunostaining. (g-i) <t>GFAP</t> immunostaining (green) and DAPI nuclei labeling (blue). (j-l) TUNEL (red, arrows) and DAPI (blue). (m, n) Bar graph of quantification of AQP-4 (m) and Kir4.1 (n) expression levels in the retina and correlation with retinal thickness. (o) Bar graph of quantification of GFAP + processes across the IPL and correlation with retinal thickness. (p) Bar graph of quantification of the number of TUNEL + cells in each retina layer per retinal section. GCL: ganglion cell layer; INL: inner nuclear layer; IPL: inner plexiform layer; OPL: outer plexiform layer, ONL: outer nuclear layer.
    Glial Fibrillary Acidic Protein Gfap, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glial fibrillary acidic protein gfap/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glial fibrillary acidic protein gfap - by Bioz Stars, 2023-01
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs glial fibrillary acidic protein gfap rabbit dako z0334
    List of primary and secondary antibodies used in the study.
    Glial Fibrillary Acidic Protein Gfap Rabbit Dako Z0334, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glial fibrillary acidic protein gfap rabbit dako z0334/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    glial fibrillary acidic protein gfap rabbit dako z0334 - by Bioz Stars, 2023-01
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs gfap
    List of primary and secondary antibodies used in the study.
    Gfap, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gfap/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    gfap - by Bioz Stars, 2023-01
    94/100 stars
      Buy from Supplier

    Image Search Results


    TRPV4 activation enhances the expression of GFAP. A Immunofluorescence images show GFAP protein expression profiles in rat retinal vertical slices acquired from sham-operated retinas (saline-injected; control) ( A1 ), 1 µM GSK101-injected retinas ( A2 ), and 10 µM GSK101-injected retinas ( A3 ). Retinas that received no GFAP antibody served as negative controls ( A4 ). Double immunofluorescence staining showing GFAP expression when the GFAP antibody was pre-adsorbed with its blocking peptide (BP) ( A5 ). Scale bar: 20 µm. B Representative immunoblots showing changes in GFAP protein levels in control and 10 µM GSK101-injected retinas. C Bar chart summarizing mean expression levels of GFAP under different conditions. n = 6. * p < 0.05 vs control

    Journal: Journal of Neuroinflammation

    Article Title: TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway

    doi: 10.1186/s12974-021-02315-8

    Figure Lengend Snippet: TRPV4 activation enhances the expression of GFAP. A Immunofluorescence images show GFAP protein expression profiles in rat retinal vertical slices acquired from sham-operated retinas (saline-injected; control) ( A1 ), 1 µM GSK101-injected retinas ( A2 ), and 10 µM GSK101-injected retinas ( A3 ). Retinas that received no GFAP antibody served as negative controls ( A4 ). Double immunofluorescence staining showing GFAP expression when the GFAP antibody was pre-adsorbed with its blocking peptide (BP) ( A5 ). Scale bar: 20 µm. B Representative immunoblots showing changes in GFAP protein levels in control and 10 µM GSK101-injected retinas. C Bar chart summarizing mean expression levels of GFAP under different conditions. n = 6. * p < 0.05 vs control

    Article Snippet: As negative controls, TRPV4 and GFAP antibodies were pre-adsorbed with TRPV4 blocking peptide (Alomone Labs) and GFAP blocking peptide (Bioss), respectively.

    Techniques: Activation Assay, Expressing, Immunofluorescence, Injection, Double Immunofluorescence Staining, Blocking Assay, Western Blot

    TRPV4 activation enhances TNF-α production in cultured Müller cells. A Morphology of cultured Müller cells. Scale bar: 50 µm. B GSK101 treatment enhanced GFAP protein levels in cultured Müller cells. n = 4. ** p < 0.01 and *** p < 0.001. C Cumulative changes in GFAP protein levels in control and GSK101 treatment groups. D – F Cumulative changes in mRNA levels of TNF-α ( D ), IL-1β ( E ), and IL-6 ( F ) in Müller cell extracts obtained after saline treatment (control) or GSK101 treatment for 24 h. Relative abundances of mRNA were quantified using the 2 −ΔΔct calculation method and are expressed as fold changes. n = 3 for all groups. * p < 0.05 vs control. G , GSK101 treatment led to enhancement of TNF-α protein level. H Cumulative changes in TNF-α protein levels in control and GSK101 treatment groups. n = 6. * p < 0.05 and *** p < 0.001

    Journal: Journal of Neuroinflammation

    Article Title: TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway

    doi: 10.1186/s12974-021-02315-8

    Figure Lengend Snippet: TRPV4 activation enhances TNF-α production in cultured Müller cells. A Morphology of cultured Müller cells. Scale bar: 50 µm. B GSK101 treatment enhanced GFAP protein levels in cultured Müller cells. n = 4. ** p < 0.01 and *** p < 0.001. C Cumulative changes in GFAP protein levels in control and GSK101 treatment groups. D – F Cumulative changes in mRNA levels of TNF-α ( D ), IL-1β ( E ), and IL-6 ( F ) in Müller cell extracts obtained after saline treatment (control) or GSK101 treatment for 24 h. Relative abundances of mRNA were quantified using the 2 −ΔΔct calculation method and are expressed as fold changes. n = 3 for all groups. * p < 0.05 vs control. G , GSK101 treatment led to enhancement of TNF-α protein level. H Cumulative changes in TNF-α protein levels in control and GSK101 treatment groups. n = 6. * p < 0.05 and *** p < 0.001

    Article Snippet: As negative controls, TRPV4 and GFAP antibodies were pre-adsorbed with TRPV4 blocking peptide (Alomone Labs) and GFAP blocking peptide (Bioss), respectively.

    Techniques: Activation Assay, Cell Culture

    Co-localization of TRPA1 and SFKs, and effects of pYEEI, the SFKs activator, on the anti-TRPA1 antibody-reduced cortical susceptibility to CSD in the mouse brain slice. ( A , B ) Representative images of expression of SFKs in neurons and astrocytes of mouse cerebral cortices. ( C ) Representative images of co-localization of TRPA1 and SFKs in mouse cerebral cortices. Staining with DAPI indicated nucleus as shown in blue; staining with the anti-TRPA1 antibody was shown in red; staining with the anti-NeuN antibody indicated neurons and staining with the anti-GFAP antibody indicated astrocytes as shown in green. Double immune-labeling showed expression of SFKs in neurons and astrocytes of mouse cerebral cortices or co-expression of TRPA1 and SFKs in mouse cerebral cortices (white arrows, n = 3 per group). ( D ) Representative images of the coronal slice of mouse brain before (upper) and after (lower) CSD induced by ejection of 260 mM KCl in the cerebral cortical region. The same area of interest (AOI) along CSD wave front (pointed by the short arrow) was selected and used for all images. ( E ) The averaged gray level within the AOI was plotted against time to generate the CSD curve. ( F , G ) Effects of 0.015 µM anti-TRPA1 antibody (Anti-TRPA1) ( n = 7), 0.015 µM anti-TRPA1 antibody + 0.1 µM pYEEI ( n = 7), or 0.015 µM anti-TRPA1 antibody + 0.1 µM YEEI ( n = 8) on CSD latency (seconds, s) and CSD propagation rate (mm/minute, mm/min) in mouse brain slices. Group data were presented as mean ± SEM. Two-tailed unpaired t -test was used for comparison between pYEEI and YEEI group in the presence of anti-TRPA1 antibody. Significance differences were shown as * p < 0.05, ** p < 0.01.

    Journal: International Journal of Molecular Sciences

    Article Title: TRPA1-Mediated Src Family Kinases Activity Facilitates Cortical Spreading Depression Susceptibility and Trigeminovascular System Sensitization

    doi: 10.3390/ijms222212273

    Figure Lengend Snippet: Co-localization of TRPA1 and SFKs, and effects of pYEEI, the SFKs activator, on the anti-TRPA1 antibody-reduced cortical susceptibility to CSD in the mouse brain slice. ( A , B ) Representative images of expression of SFKs in neurons and astrocytes of mouse cerebral cortices. ( C ) Representative images of co-localization of TRPA1 and SFKs in mouse cerebral cortices. Staining with DAPI indicated nucleus as shown in blue; staining with the anti-TRPA1 antibody was shown in red; staining with the anti-NeuN antibody indicated neurons and staining with the anti-GFAP antibody indicated astrocytes as shown in green. Double immune-labeling showed expression of SFKs in neurons and astrocytes of mouse cerebral cortices or co-expression of TRPA1 and SFKs in mouse cerebral cortices (white arrows, n = 3 per group). ( D ) Representative images of the coronal slice of mouse brain before (upper) and after (lower) CSD induced by ejection of 260 mM KCl in the cerebral cortical region. The same area of interest (AOI) along CSD wave front (pointed by the short arrow) was selected and used for all images. ( E ) The averaged gray level within the AOI was plotted against time to generate the CSD curve. ( F , G ) Effects of 0.015 µM anti-TRPA1 antibody (Anti-TRPA1) ( n = 7), 0.015 µM anti-TRPA1 antibody + 0.1 µM pYEEI ( n = 7), or 0.015 µM anti-TRPA1 antibody + 0.1 µM YEEI ( n = 8) on CSD latency (seconds, s) and CSD propagation rate (mm/minute, mm/min) in mouse brain slices. Group data were presented as mean ± SEM. Two-tailed unpaired t -test was used for comparison between pYEEI and YEEI group in the presence of anti-TRPA1 antibody. Significance differences were shown as * p < 0.05, ** p < 0.01.

    Article Snippet: Slices were incubated in 10% goat serum (AR0009 Boster Biological Technology, Pleasanton, CA, USA) at room temperature (RT) for 2 h. Brain slices were incubated in anti-SFKs antibody (1:80, AF3389 R&D Systems, Minneapolis, MN, USA) with anti-NeuN antibody (1:500, MAB377 Merck, St. Louis, MO, USA), or anti-GFAP antibody (1:100, 3670 CST, Beverly, MA, USA) or anti-TRPA1 antibody (1:100, ACC-037 Alomone Labs, Jerusalem, Israel), respectively at 4 °C overnight.

    Techniques: Slice Preparation, Expressing, Staining, Labeling, Two Tailed Test

    (a) AQP-4 immunostaining of retina in control (a), 1h (b) and 18h (c) animals. (d-f) Kir4.1 immunostaining. (g-i) GFAP immunostaining (green) and DAPI nuclei labeling (blue). (j-l) TUNEL (red, arrows) and DAPI (blue). (m, n) Bar graph of quantification of AQP-4 (m) and Kir4.1 (n) expression levels in the retina and correlation with retinal thickness. (o) Bar graph of quantification of GFAP + processes across the IPL and correlation with retinal thickness. (p) Bar graph of quantification of the number of TUNEL + cells in each retina layer per retinal section. GCL: ganglion cell layer; INL: inner nuclear layer; IPL: inner plexiform layer; OPL: outer plexiform layer, ONL: outer nuclear layer.

    Journal: PLoS ONE

    Article Title: Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes

    doi: 10.1371/journal.pone.0246681

    Figure Lengend Snippet: (a) AQP-4 immunostaining of retina in control (a), 1h (b) and 18h (c) animals. (d-f) Kir4.1 immunostaining. (g-i) GFAP immunostaining (green) and DAPI nuclei labeling (blue). (j-l) TUNEL (red, arrows) and DAPI (blue). (m, n) Bar graph of quantification of AQP-4 (m) and Kir4.1 (n) expression levels in the retina and correlation with retinal thickness. (o) Bar graph of quantification of GFAP + processes across the IPL and correlation with retinal thickness. (p) Bar graph of quantification of the number of TUNEL + cells in each retina layer per retinal section. GCL: ganglion cell layer; INL: inner nuclear layer; IPL: inner plexiform layer; OPL: outer plexiform layer, ONL: outer nuclear layer.

    Article Snippet: Retinae were immunostained with primary antibodies to detect and AQP-4 (1:50, mouse; catalog number sc-32739, Santa Cruz Biotechnology, Inc. Dallas, Texas, USA), Kir4.1 (1:200, rabbit, catalog number APC-035, Alomone Labs, Jerusalem, Israel) and glial fibrillary acidic protein (GFAP) (1:1000, rabbit; catalog number ab7260; Abcam, Cambridge, MA, USA).

    Techniques: Immunostaining, Labeling, TUNEL Assay, Expressing

    List of primary and secondary antibodies used in the study.

    Journal: Neurobiology of disease

    Article Title: TAF1 -gene editing alters the morphology and function of the cerebellum

    doi: 10.1016/j.nbd.2019.104539

    Figure Lengend Snippet: List of primary and secondary antibodies used in the study.

    Article Snippet: Similar control experiments were performed for the other antibodies used in this study (data not shown). table ft1 table-wrap mode="anchored" t5 Table 1. caption a7 Primary antibodies Anti- Abbreviation Host Company Catalog number Dilution a TATA-box binding protein factor 1 TAF1 Rabbit Sigma Aldrich AV32473 1:500 Calbindin-D28k Calbindin Rabbit Sigma Aldrich C2724 1:250 Low-Voltage-Activated CaV3.1 Calcium Channels CaV3.1 Rabbit Almone labs ACC-021 1:250 Glial fibrillary acidic protein GFAP Rabbit Dako Z0334 1:250 Ionizing calcium-binding adaptor molecule 1 Iba1 Rabbit Wako Labs 019-19741 1:250 Red fluorescent protein TagRFP tRFP Rabbit Envitrogen AB233 1:250 Tublin Tublin Mouse Promega G7121 1:250 Secondary antibodies Anti- Host Label Dilution Company Rabbit IgG Goat Alexa 488 1:250 Life technologies Rabbit IgG Goat Alexa 594 1:250 Promega Mouse IgG Goat Alexa 594 1:250 Promega Open in a separate window a Dilutions were from original stocks supplied by the vendors List of primary and secondary antibodies used in the study.

    Techniques: Binding Assay

    (A) Expression of calbindin was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of Calbindin positive Purkinje cells in TAF1-edited animals compared to control animals. B) Expression of GFAP (astrocytes marker) was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of GFAP positive cells in TAF1-edited animals compared to control animals. (C) Expression of Iba1 (microglia marker) was increased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also increase in the number of Iba1 positive cells in TAF1-edited animals compared to control animals. (D) Summary of the number of Purkinje cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 12 fields per animal, 4 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). (E) and (F) Summary of the number of GFAP positive cells and Iba1 positive cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 9 fields per animal, 3 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). The experiments were conducted in an investigator blinded manner.

    Journal: Neurobiology of disease

    Article Title: TAF1 -gene editing alters the morphology and function of the cerebellum

    doi: 10.1016/j.nbd.2019.104539

    Figure Lengend Snippet: (A) Expression of calbindin was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of Calbindin positive Purkinje cells in TAF1-edited animals compared to control animals. B) Expression of GFAP (astrocytes marker) was decreased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also a decrease in the number of GFAP positive cells in TAF1-edited animals compared to control animals. (C) Expression of Iba1 (microglia marker) was increased in TAF1-edited animals as compared to naïve and CRISPR-control groups. Note also increase in the number of Iba1 positive cells in TAF1-edited animals compared to control animals. (D) Summary of the number of Purkinje cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 12 fields per animal, 4 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). (E) and (F) Summary of the number of GFAP positive cells and Iba1 positive cells per linear density in each of the experimental conditions. Data are shown as mean ± S.E.M., n = 9 fields per animal, 3 animals per experimental condition. *p<0.05 versus; naïve, #p<0.05 versus gRNA-control (ANOVA followed by Tukey’s test). The experiments were conducted in an investigator blinded manner.

    Article Snippet: Similar control experiments were performed for the other antibodies used in this study (data not shown). table ft1 table-wrap mode="anchored" t5 Table 1. caption a7 Primary antibodies Anti- Abbreviation Host Company Catalog number Dilution a TATA-box binding protein factor 1 TAF1 Rabbit Sigma Aldrich AV32473 1:500 Calbindin-D28k Calbindin Rabbit Sigma Aldrich C2724 1:250 Low-Voltage-Activated CaV3.1 Calcium Channels CaV3.1 Rabbit Almone labs ACC-021 1:250 Glial fibrillary acidic protein GFAP Rabbit Dako Z0334 1:250 Ionizing calcium-binding adaptor molecule 1 Iba1 Rabbit Wako Labs 019-19741 1:250 Red fluorescent protein TagRFP tRFP Rabbit Envitrogen AB233 1:250 Tublin Tublin Mouse Promega G7121 1:250 Secondary antibodies Anti- Host Label Dilution Company Rabbit IgG Goat Alexa 488 1:250 Life technologies Rabbit IgG Goat Alexa 594 1:250 Promega Mouse IgG Goat Alexa 594 1:250 Promega Open in a separate window a Dilutions were from original stocks supplied by the vendors List of primary and secondary antibodies used in the study.

    Techniques: Expressing, CRISPR, Marker